- Home
- ASMB vs PHD Comparison
ASMB vs PHD Comparison
Compare ASMB & PHD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASMB
- PHD
- Stock Information
- Founded
- ASMB 2005
- PHD 2004
- Country
- ASMB United States
- PHD United States
- Employees
- ASMB N/A
- PHD N/A
- Industry
- ASMB Biotechnology: Pharmaceutical Preparations
- PHD Investment Managers
- Sector
- ASMB Health Care
- PHD Finance
- Exchange
- ASMB Nasdaq
- PHD Nasdaq
- Market Cap
- ASMB 141.8M
- PHD 120.3M
- IPO Year
- ASMB 2010
- PHD N/A
- Fundamental
- Price
- ASMB $18.51
- PHD $9.86
- Analyst Decision
- ASMB Strong Buy
- PHD
- Analyst Count
- ASMB 3
- PHD 0
- Target Price
- ASMB $33.00
- PHD N/A
- AVG Volume (30 Days)
- ASMB 43.3K
- PHD 67.7K
- Earning Date
- ASMB 08-07-2025
- PHD 01-01-0001
- Dividend Yield
- ASMB N/A
- PHD 11.43%
- EPS Growth
- ASMB N/A
- PHD N/A
- EPS
- ASMB N/A
- PHD 1.27
- Revenue
- ASMB $32,154,000.00
- PHD N/A
- Revenue This Year
- ASMB $0.04
- PHD N/A
- Revenue Next Year
- ASMB N/A
- PHD N/A
- P/E Ratio
- ASMB N/A
- PHD $7.60
- Revenue Growth
- ASMB 148.33
- PHD N/A
- 52 Week Low
- ASMB $7.75
- PHD $8.30
- 52 Week High
- ASMB $19.93
- PHD $9.81
- Technical
- Relative Strength Index (RSI)
- ASMB 63.34
- PHD 57.12
- Support Level
- ASMB $18.13
- PHD $9.86
- Resistance Level
- ASMB $19.11
- PHD $9.95
- Average True Range (ATR)
- ASMB 0.81
- PHD 0.05
- MACD
- ASMB -0.06
- PHD -0.00
- Stochastic Oscillator
- ASMB 77.83
- PHD 52.63
About ASMB Assembly Biosciences Inc.
Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.
About PHD Pioneer Floating Rate Fund Inc.
Pioneer Floating Rate Trust is a diversified, closed-end fund. It invests in the fixed income markets of the United States. The fund basically invests in senior secured floating-rate loans. It benchmarks the performance of its portfolio against the other High Yield Loans Index banks.